Loomis Sayles & CO L P Vertex Pharmaceuticals Inc Transaction History
Loomis Sayles & CO L P
- $77.3 Billion
- Q2 2025
A detailed history of Loomis Sayles & CO L P transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Loomis Sayles & CO L P holds 3,813,378 shares of VRTX stock, worth $1.6 Billion. This represents 2.2% of its overall portfolio holdings.
Number of Shares
3,813,378
Previous 3,748,331
1.74%
Holding current value
$1.6 Billion
Previous $1.82 Billion
6.58%
% of portfolio
2.2%
Previous 2.63%
Shares
23 transactions
Others Institutions Holding VRTX
# of Institutions
1,785Shares Held
236MCall Options Held
1.95MPut Options Held
1.14M-
Capital World Investors Los Angeles, CA28.7MShares$12.1 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$10.1 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.95 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.76 Billion1.5% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.94 Billion0.2% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $108B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...